News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
European Medicines Agency’s CHMP Issues Favorable Opinion for GSK’s Arexvy Vaccine for Adults Aged 50-59 at Higher Risk of RSV
Monday, July 29, 2024GSK plc has revealed that the European Medicines Agencys Committee for Medicinal Products for Human Use CHMP has recommended broadening the approval of GSKs RSV vaccine
Presage Biosciences Starts Initial Patient Dosing of Pure Biologics' Antibody Targeting ROR1 for Cancer Therapy
Friday, July 26, 2024Presage Biosciences known for its expertise in evaluating oncology drugs within human tumors has initiated Phase dosing with PBA an antibody from Pure Biologics that targets ROR
Kashiv BioSciences Concludes Patient Enrollment for Phase III Study of ADL018, a Biosimilar to XOLAIR® (omalizumab)
Friday, July 26, 2024Kashiv BioSciences LLC has completed patient enrollment for its Phase III clinical trial of ADL a biosimilar candidate to XOLAIR This pivotal trial is designed to assess how ADL compares to XOLAIR
Dren Bio and Novartis Forge Collaboration to Develop Innovative Targeted Myeloid Engagers for Cancer Treatment
Thursday, July 25, 2024Dren Bio Inc a private clinicalstage biopharmaceutical company has announced a strategic collaboration with Novartis Pharma AG a subsidiary of Novartis AG This partnership aims to advance the discovery
Charles River Laboratories and Autobahn Labs Join Forces to Expedite Academic Drug Discovery
Thursday, July 25, 2024Charles River Laboratories International Inc and Autobahn Labs a virtual accelerator for academic biotech supported by Samsara BioCapital have unveiled a strategic collaboration Charles River
Oisín Biotechnologies Raises $15 Million in Series A Round to Advance Age-Related Disease Treatments
Thursday, July 25, 2024Oisn Biotechnologies a private biotech company focused on combating agerelated diseases has announced the initial close of its million Series A funding round AbbVie Ventures led this first tranche
ViroCell Biologics Forms Master Services Agreement with Top NCI-Designated Cancer Center
Wednesday, July 24, 2024ViroCell Biologics a contract development and manufacturing organization specializing in GMP viral vector production has secured a fiveyear Master Services Agreement MSA with a major US
Pinetree Therapeutics Enters Exclusive Global Licensing Deal with AstraZeneca for Preclinical EGFR Degrader
Wednesday, July 24, 2024Pinetree Therapeutics Inc a biotechnology firm at the forefront of developing nextgeneration targeted protein degrades to overcome drug resistance in oncology and other fields
KBI Biopharma Enhances Contract with Major Global Pharmaceutical Partner After Passing FDA Inspection
Wednesday, July 24, 2024KBI Biopharma Inc a division of JSR Life Sciences and a prominent contract development and manufacturing organization has announced a significant extension and expansion of its manufacturing
Oxford Nanopore Technologies and Plasmidsaurus Partner to Advance Plasmid Sequencing Technology
Wednesday, July 24, 2024Oxford Nanopore Technologies and Plasmidsaurus have entered into an expanded multiyear collaboration to transform the plasmid sequencing industry using advanced nanopore technology
